Your browser doesn't support javascript.
loading
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes.
Kapitza, Laura; Ho, Naphang; Kerzel, Thomas; Frank, Annika M; Thalheimer, Frederic B; Jamali, Arezoo; Schaser, Thomas; Buchholz, Christian J; Hartmann, Jessica.
Affiliation
  • Kapitza L; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Ho N; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kerzel T; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Frank AM; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Thalheimer FB; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Jamali A; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Schaser T; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
  • Buchholz CJ; Research & Development, Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Hartmann J; Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.
Front Immunol ; 14: 1183698, 2023.
Article in En | MEDLINE | ID: mdl-37646032
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Germany